Citius Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 11/14/2024 | 7.28 M | $3.64 M | -28.36% | 4.19% |
| VANGUARD GROUP INC | 11/13/2024 | 6.44 M | $3.23 M | 1.79% | 3.70% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 1.88 M | $940,790 | 14.13% | 1.08% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 1.81 M | $903,946 | 100.00% | 1.04% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 1.16 M | $579,949 | -43.46% | 0.67% |
| ADVISOR GROUP HOLDINGS, INC. | 11/13/2024 | 931,833 | $466,451 | -0.05% | 0.54% |
| SQUAREPOINT OPS LLC | 11/14/2024 | 659,379 | $330,085 | 100.00% | 0.38% |
| STATE STREET CORP | 11/14/2024 | 581,797 | $291,248 | 0.00% | 0.33% |
| CHELSEA COUNSEL CO | 11/21/2024 | 281,300 | $140,819 | 9.75% | 0.16% |
| HIGHTOWER ADVISORS, LLC | 11/14/2024 | 215,020 | $107,000 | 0.00% | 0.12% |
| WEALTH ADVISORY SOLUTIONS, LLC | 10/21/2024 | 201,000 | $100,621 | 33.11% | 0.12% |
| ARKADIOS WEALTH ADVISORS | 10/24/2024 | 200,000 | $100,120 | 33.33% | 0.12% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 165,063 | $82,630 | -74.23% | 0.09% |
| INSPIRE ADVISORS, LLC | 10/17/2024 | 157,938 | $79,064 | -0.19% | 0.09% |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 11/14/2024 | 100,535 | $50,328 | -50.20% | 0.06% |
| VIRTU FINANCIAL LLC | 11/20/2024 | 100,406 | $50,000 | 100.00% | 0.06% |
| MILLER INVESTMENT MANAGEMENT, LP | 11/14/2024 | 99,640 | $49,880 | 99.28% | 0.06% |
| JANE STREET GROUP, LLC | 11/15/2024 | 93,446 | $46,779 | -75.64% | 0.05% |
| XTX TOPCO LTD | 11/14/2024 | 93,259 | $46,685 | 100.00% | 0.05% |
| KESTRA ADVISORY SERVICES, LLC | 11/13/2024 | 92,519 | $46,315 | -1.14% | 0.05% |
| BLAIR WILLIAM & CO/IL | 11/12/2024 | 91,200 | $45,655 | -5.20% | 0.05% |
| CITADEL ADVISORS LLC | 11/14/2024 | 83,100 | $41,600 | 236.44% | 0.05% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 76,073 | $38,082 | 0.00% | 0.04% |
| HORST & GRABEN WEALTH MANAGEMENT LLC | 10/21/2024 | 75,722 | $37,906 | 0.00% | 0.04% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 72,088 | $36,087 | -68.79% | 0.04% |
| PRIVATE ADVISOR GROUP, LLC | 10/22/2024 | 40,000 | $20,024 | -0.05% | 0.02% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 37,940 | $18,993 | -96.80% | 0.02% |
| HRT FINANCIAL LP | 11/12/2024 | 37,182 | $18,000 | -62.85% | 0.02% |
| CITADEL ADVISORS LLC | 11/14/2024 | 32,100 | $16,069 | 100.00% | 0.02% |
| TCG ADVISORY SERVICES, LLC | 11/14/2024 | 30,000 | $15,018 | 0.00% | 0.02% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 28,930 | $14,465 | -81.85% | 0.02% |
| 11/14/2024 | 27,200 | $13,616 | 0.00% | 0.02% | |
| VICTORY CAPITAL MANAGEMENT INC | 11/05/2024 | 21,372 | $10,699 | -1.68% | 0.01% |
| GROUP ONE TRADING, L.P. | 11/14/2024 | 20,650 | $10,337 | -13.42% | 0.01% |
| FINANCIAL ENGINES ADVISORS L.L.C. | 11/12/2024 | 20,000 | $10,012 | 100.00% | 0.01% |
| KEYNOTE FINANCIAL SERVICES LLC | 10/31/2024 | 17,500 | $8,761 | 0.00% | 0.01% |
| CSENGE ADVISORY GROUP | 11/13/2024 | 15,000 | $5,508 | 0.00% | 0.01% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 14,633 | $7,325 | 0.01% | 0.01% |
| 11/25/2024 | 12,500 | $1,673 | 100.00% | 0.01% | |
| LPL FINANCIAL LLC | 11/08/2024 | 11,485 | $5,749 | -81.32% | 0.01% |
| ETHOS FINANCIAL GROUP, LLC | 11/07/2024 | 10,000 | $5,000 | 0.00% | 0.01% |
| FAIRSCALE CAPITAL, LLC | 11/12/2024 | 9,155 | $4,583 | 0.00% | 0.01% |
| SIMPLEX TRADING, LLC | 11/08/2024 | 8,543 | $4,000 | -19.87% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2024 | 4,044 | $2,024 | -90.71% | 0.00% |
| PRINCETON GLOBAL ASSET MANAGEMENT LLC | 10/29/2024 | 4,000 | $2,002 | 0.00% | 0.00% |
| JPMORGAN CHASE & CO | 11/08/2024 | 3,041 | $1,522 | 0.00% | 0.00% |
| RONALD BLUE TRUST, INC. | 10/17/2024 | 3,000 | $1,751 | 0.00% | 0.00% |
| QUENT CAPITAL, LLC | 10/04/2024 | 2,752 | $1,378 | 0.00% | 0.00% |
| MORGAN STANLEY | 11/14/2024 | 1,500 | $751 | -84.60% | 0.00% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 11/14/2024 | 1,301 | $651 | -98.90% | 0.00% |
Citius Pharmaceuticals, Inc.institutional Ownership - FAQ's
During the previous two years, 82 institutional investors and hedge funds held shares of Citius Pharmaceuticals, Inc.. The most heavily invested institutionals were:
ARMISTICE CAPITAL, LLC: 7.28 M
VANGUARD GROUP INC: 6.44 M
GEODE CAPITAL MANAGEMENT, LLC: 1.88 M
BlackRock Funding, Inc. /DE: 1.81 M
MILLENNIUM MANAGEMENT LLC: 1.16 M
ADVISOR GROUP HOLDINGS, INC.: 931,833
13.56% of Citius Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 25.40 M shares in the last 24 months. This purchase volume represents approximately $66.04 M in transactions.